(Q24317342)

positive regulation of cell cycle G1/S phase transition

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

hepatocellular carcinoma

1 reference

Dong Wang

1

0 references

Sheng Han

2

0 references

Rui Peng

3

0 references

Xing Wang

4

0 references

Xin-Xiang Yang

5

0 references

Ren-Jie Yang

6

0 references

Chen-Yu Jiao

7

0 references

Dong Ding

8

0 references

Gu-Wei Ji

9

0 references

Xiang-Cheng Li

Biochemical and Biophysical Research Communications

10

0 references

language of work or name

English

0 references

publication date

6 March 2015

0 references

published in

0 references

volume

458

0 references

issue

2

0 references

page(s)

313-20

0 references

cites work

Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

Fibroblast growth factor signaling in liver carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

X chromosomal abnormalities in basal-like human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

A metastatic signature in entire lung adenocarcinomas irrespective of morphological heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

Hepatitis viruses and the MAPK pathway: is this a survival strategy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

Hepatocellular carcinoma pathogenesis: from genes to environment

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

Medical therapies for hepatocellular carcinoma: a critical view of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

RNAi-mediated ERK2 knockdown inhibits growth of tumor cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

Hepatocellular carcinoma: clinical frontiers and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

FAM83B mediates EGFR- and RAS-driven oncogenic transformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

JNK1 activation predicts the prognostic outcome of the human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

From basic research to clinical development of MEK1/2 inhibitors for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

Identification of candidate growth promoting genes in ovarian cancer through integrated copy number and expression analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

BJ-TSA-9, a novel human tumor-specific gene, has potential as a biomarker of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2015.01.108

7 January 2021